IBX

4.35%

4.8¢ imagion biosystems limited

Ann: IBX Investor Webcast Presentation, page-42

First 42 Last

Share
Profile

Follow
squarepants

881 Posts.

74

24/06/20

17:36

Post #: 45426758
Share

Originally posted by shanni: ↑

I've had a chance to look at the webcast this afternoon and was impressed with Bob's presentation.

Positives:
- The trial will not only be focusing on safety, but will also collect some preliminary information about the accuracy of the nanoparticles. This is great news, since we will have an early indication of how the next larger in human trial will go.
- The trials will allow IBX to look at both MRI and Magsense
- I can't see patient recruitment being a major issue, particularly if they partner with some large centres in Sydney and Melbourne
- The scientific advisory board consists of multiple well-connected clinicians from a good spread of different fields. I certainly feel comfortable that the company is receiving expert medical advice.

Negatives:
- Cap raise required prior to the trial
- Ethics approval: this may take longer than expected. I would not be surprised if the trial was delayed due to this.
- Impact of Covid-19: who knows what will happen over the rest of the year, but this could potentially disrupt trials.

Overall
- Good to see progress being made, although there is plenty still to be done.
- If trial results are positive, i.e. safety is established and initial results in terms of accuracy are promising, then the company is significantly derisked.
- We all need to be patient, since this process will likely take another 12 months if not longer, with a cap raise that will probably tank the share price later this year as well.
- I was thinking of buying more shares, but now I think it's better to participate in the cap raise and maybe snap up some cheaper shares if the price falls at this time.

Would be interesting to see how others feel.

Expand

Good post Shanni, seems to me some excessive exuberance about the stock in some posts. I am a bit dissapointed by your negatives but suspect you are realistic.

IBX Price at posting: 3.1¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 42 Last

Add IBX (ASX) to my watchlist

(20min delay)
Last 4.8¢		Change 0.002(4.35%)		Mkt cap ! $2.065M

Open	High	Low	Value	Volume
4.5¢	4.8¢	4.5¢	$7.822K	164.4K

Buyers (Bids)

No.	Vol.	Price($)
2	69259	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.8¢	31838	1

View Market Depth

No.	Vol.	Price($)
2	69259	0.045
1	15000	0.043
1	100000	0.042
2	17560	0.041
4	245000	0.040

Price($)	Vol.	No.
0.048	31838	1
0.050	1550	1
0.059	201775	1
0.060	10000	1
0.062	13574	1

Last trade - 16.10pm 15/11/2024 (20 minute delay)

IBX (ASX) Chart

Ann: IBX Investor Webcast Presentation, page-42

Banshee's historic trenches prove rich in antimony and gold for GDM

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: IBX Investor Webcast Presentation, page-42

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 46, 2024

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News